Uncategorized

Gismo Therapeutics Inc. Receives Funding to Develop Novel Therapeutics for Parkinson’s Disease and for Amyotrophic Lateral Sclerosis (ALS)

Company Gets Grants from the Michael J. Fox Foundation for Parkinson’s Research and from the Department of Defense. LEXINGTON, KY. and NEW YORK, NY. (June 16, 2022) – Gismo Therapeutics Inc. has been awarded two new grants to continue development of therapies to treat Parkinson’s Disease and Amyotrophic Lateral Sclerosis (ALS). A $280,000 grant entitled [...]

Go to Top